The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2024 / Articles / Dec / Redefining Sterile Manufacturing Standards with Kindeva
Discovery & Development Outsourcing Technology & Manufacturing Sponsored

Redefining Sterile Manufacturing Standards with Kindeva

12/06/2024 8 min read Video

Sponsored By

Kindeva

Share

Milton Boyer and Dave Stevens from Kindeva Drug Delivery delve into the company’s evolution and expertise in sterile manufacturing and drug delivery systems. Check out the video to find out more about their new, 200,000-square-foot facility in Bridgeton, which is designed to meet and exceed Annex 1 regulatory requirements, as well as how the company is responding to trends in green propellants for metered dose inhalers.

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Recommended

Related Content

Musings from The Power List: Ali Pashazadeh
Outsourcing Biopharma Business & Trends
Musings from The Power List: Ali Pashazadeh

August 7, 2026

7 min read

Ali Pashazadeh argues that management failures sink too many clinical programs – and explains why commercial discipline must start much earlier

The Confidentiality Barrier to AI-Enabled Drug Development
Small Molecules Small Molecules Formulation
The Confidentiality Barrier to AI-Enabled Drug Development

July 27, 2026

3 min read

AI can help formulation teams better predict performance and allocate resources, but proprietary data protections remain a critical bottleneck

The Rise of China: From Science Cities to Global Ambition
Outsourcing Regulation & Standards Biopharma
The Rise of China: From Science Cities to Global Ambition

July 15, 2026

8 min read

Daphne Smyth of Veristat on the rise of Chinese biopharma, regulatory realities, and what comes next

Biopharma Vital Signs – Part 4: The New Partnership Playbook
Outsourcing Biopharma
Biopharma Vital Signs – Part 4: The New Partnership Playbook

July 10, 2026

14 min read

Experts discuss how biopharma partnerships are evolving, as companies look beyond transactional supplier relationships toward more integrated, strategic, and collaborative models

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions: